Overview

Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutics in areas of unmet medical need. With a portfolio of drugs in various stages of development, the company is known for its work in the fields of HIV, liver diseases, and cancer.

Core services & business areas

Pharmaceutical DistributionSupply Chain ManagementRegulatory Affairs

Therapeutic areas

HIV/AIDSLiver diseasesCancerInflammatory diseasesRespiratory diseases

Active pharmaceutical ingredients supplied

Substances Gilead Sciences, Inc. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Gilead Sciences, Inc. holds 3 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • COBICISTAT ON SILICON DIOXIDEActive2011-10-24
  • ELVITEGRAVIRActive2011-10-21
  • AMBISOME, LIPOSOMAL AMPHOTERICIN BActive1992-03-06
  • LIPOSOMAL LURTOTECAN FOR INJECTION (OSI-211)Inactive2002-11-06
  • LIPOSOMAL OSI-7904 FOR INJECTION (OSI-7904L)Inactive2002-06-28
  • FK506LC AND PLACEBOInactive2001-10-12
  • PMPA GELInactive1997-10-07

FDA compliance signals

30 FDA enforcement records linked to this company.

  • 4832026-02-18

    Sterility/pyrogens - test methods written, followed

  • 4832026-02-18

    Procedures for sterile drug products

  • 4832026-02-18

    Procedures not in writing, fully followed

  • 4832026-02-18

    Reserve samples identified, representative, stored

  • 4832026-02-18

    Following/documenting laboratory controls

  • 4832026-02-18

    Scientifically sound laboratory controls

  • 4832026-02-18

    Annual visual exams of drug products

  • recall — Class I2024-10-09

    Presence of Particulate Matter: Presence of glass particle.

  • 4832024-01-22

    Late submission of 15-day report

  • recall — Class I2022-01-05

    Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

  • 4832021-12-17

    Buildings not maintained in good state of repair

  • 4832021-12-17

    Training , Education , Experience overall

  • 4832021-12-17

    Procedures not in writing, fully followed

  • 4832021-12-17

    Validation lacking for sterile drug products

  • 4832018-07-17

    Late submission of 15-day report

Verified Supplier Partner

Is this Gilead Sciences, Inc.? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.